121 related articles for article (PubMed ID: 7902763)
1. Cell proliferation in breast carcinoma assessed by a PCNA grading system and its relation to other prognostic variables.
Betta PG; Bottero G; Pavesi M; Pastormerlo M; Bellinger D; Tallarida F
Surg Oncol; 1993; 2(1):59-63. PubMed ID: 7902763
[TBL] [Abstract][Full Text] [Related]
2. Cell proliferation in breast tumours: analysis of histological parameters Ki67 and PCNA expression.
Sullivan RP; Mortimer G; Muircheartaigh IO
Ir J Med Sci; 1993 Sep; 162(9):343-7. PubMed ID: 7903289
[TBL] [Abstract][Full Text] [Related]
3. Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score.
Tahan SR; Neuberg DS; Dieffenbach A; Yacoub L
Cancer; 1993 Jun; 71(11):3552-9. PubMed ID: 8098267
[TBL] [Abstract][Full Text] [Related]
4. [Value of immunohistochemical determination of receptors, tissue proteases, tumor suppressor proteins and proliferation markers as prognostic indicators in primary breast carcinoma].
Göhring UJ; Scharl A; Ahr A
Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):177-83. PubMed ID: 8682282
[TBL] [Abstract][Full Text] [Related]
5. Expression of proliferating cell nuclear antigen (PCNA) in gastric carcinoma: no evidence for prognostic value.
Mangham DC; Rowlands DC; Newbold KM; Reynolds GM; Fielding JW; Hallissey MT
J Clin Pathol; 1994 May; 47(5):473-4. PubMed ID: 7913101
[TBL] [Abstract][Full Text] [Related]
6. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.
Narita T; Funahashi H; Satoh Y; Takagi H
Jpn J Clin Oncol; 1993 Feb; 23(1):20-5. PubMed ID: 8096256
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of proliferating cell nuclear antigen in gastric carcinoma.
Jain S; Filipe MI; Hall PA; Waseem N; Lane DP; Levison DA
J Clin Pathol; 1991 Aug; 44(8):655-9. PubMed ID: 1679766
[TBL] [Abstract][Full Text] [Related]
8. Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma.
Thomas M; Noguchi M; Kitagawa H; Kinoshita K; Miyazaki I
J Clin Pathol; 1993 Jun; 46(6):525-8. PubMed ID: 8101192
[TBL] [Abstract][Full Text] [Related]
9. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
Siitonen SM; Kallioniemi OP; Isola JJ
Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
Markiewski M; Domagała W
Pol J Pathol; 1996; 47(4):189-94. PubMed ID: 9097711
[TBL] [Abstract][Full Text] [Related]
11. Minimal breast cancer: analysis of proliferative activity using a monoclonal antibody to proliferating cell nuclear antigen (PCNA) and its relationship to histological grade and prognosis.
Lanzafame S; Magro G; Broggi B
Pathologica; 1994 Apr; 86(2):150-6. PubMed ID: 7936757
[TBL] [Abstract][Full Text] [Related]
12. Proliferating-cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancer.
Aaltomaa S; Lipponen P; Papinaho S; Syrjänen K
J Cancer Res Clin Oncol; 1993; 119(5):288-94. PubMed ID: 8095051
[TBL] [Abstract][Full Text] [Related]
13. Topoisomerase II alpha and microtubule-associated protein-tau as a predictive marker in axillary lymph node positive breast cancer.
Won HS; Lee KE; Sung SH; Choi MY; Jo JY; Nam EM; Mun YC; Seong CM; Lee SN
Tumori; 2014; 100(1):80-6. PubMed ID: 24675496
[TBL] [Abstract][Full Text] [Related]
14. PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables.
Leonardi E; Girlando S; Serio G; Mauri FA; Perrone G; Scampini S; Dalla Palma P; Barbareschi M
J Clin Pathol; 1992 May; 45(5):416-9. PubMed ID: 1350788
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinomas: comparison with clinical and pathologic variables.
Frierson HF
Mod Pathol; 1993 May; 6(3):290-4. PubMed ID: 8102204
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of proliferating cell nuclear antigen in lymph node-negative breast cancer patients.
Bianchi S; Paglierani M; Zampi G; Cardona G; Cataliotti L; Bonardi R; Zappa M; Ciatto S
Cancer; 1993 Jul; 72(1):120-5. PubMed ID: 8099532
[TBL] [Abstract][Full Text] [Related]
17. Proliferating cell nuclear antigen (PCNA) immunostaining--a prognostic factor in ovarian cancer?
Thomas H; Nasim MM; Sarraf CE; Alison MR; Love S; Lambert HE; Price P
Br J Cancer; 1995 Feb; 71(2):357-62. PubMed ID: 7841053
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of cell proliferation in breast cancer as determined by proliferating cell nuclear antigen (PCNA) immunostaining.
Aaltomaa S; Lipponen P; Syrjänen K
Anticancer Res; 1992; 12(4):1281-6. PubMed ID: 1380227
[TBL] [Abstract][Full Text] [Related]
19. Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters.
Harper ME; Glynne-Jones E; Goddard L; Wilson DW; Matenhelia SS; Conn IG; Peeling WB; Griffiths K
Prostate; 1992; 20(3):243-53. PubMed ID: 1374182
[TBL] [Abstract][Full Text] [Related]
20. PCNA/cyclin expression in breast carcinomas: its relationships with Ki-67, ER, PgR immunostainings and clinico-pathologic aspects.
Tuccari G; Rizzo A; Muscarà M; Giuffrè G; Barresi G
Pathologica; 1993; 85(1095):47-55. PubMed ID: 8100059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
